THC Therapeutics, Inc. has announced the termination of its Share Exchange Agreement with ST Holdings Group, LLC, a decision made on October 30, 2026. The termination arises from challenges in accounting for the transaction, prompting both parties to mutually agree to end the agreement. This move is significant for THC Therapeutics as it navigates its future acquisition strategies.

THC Therapeutics, Inc. operates within the farm machinery and equipment sector, as classified under SIC code 3523. The company has undergone various changes over the years, including a name change from Harmonic Energy, Inc. in 2010. THC Therapeutics is a smaller reporting company and has filed several reports with the SEC, including a recent 10-K on February 27, 2026, and multiple 8-K forms throughout 2025 and 2026.

The SEC filing states, "On October 30, 2026, THC Therapeutics, Inc. terminated the Share Exchange Agreement... due to the difficulty in accounting for the transaction." Following this termination, THC Therapeutics and ST Holdings are reportedly in discussions regarding the potential future acquisition of some or all of ST Holdings' assets.

This decision may impact various stakeholders, including investors, employees, and partners of THC Therapeutics. The termination of the agreement could alter the company's growth trajectory and strategic direction, particularly in how it approaches future acquisitions.

Looking ahead, the filing does not specify what steps will follow this termination. However, THC Therapeutics is exploring options for acquiring assets from ST Holdings, which may lead to new developments in the near future.